468 related articles for article (PubMed ID: 33152916)
21. Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19.
Şenkal N; Meral R; Medetalibeyoğlu A; Konyaoğlu H; Kose M; Tukek T
Anatol J Cardiol; 2020 Jul; 24(1):21-29. PubMed ID: 32628137
[TBL] [Abstract][Full Text] [Related]
22. [Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].
Kreutz R; Abd El-Hady Algharably E; Ganten D; Messerli F
Pneumologie; 2020 Sep; 74(9):611-614. PubMed ID: 32916743
[No Abstract] [Full Text] [Related]
23. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors.
Stilhano RS; Costa AJ; Nishino MS; Shams S; Bartolomeo CS; Breithaupt-Faloppa AC; Silva EA; Ramirez AL; Prado CM; Ureshino RP
FASEB J; 2020 Nov; 34(11):14103-14119. PubMed ID: 32965736
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 and Cardiovascular Disease.
Clerkin KJ; Fried JA; Raikhelkar J; Sayer G; Griffin JM; Masoumi A; Jain SS; Burkhoff D; Kumaraiah D; Rabbani L; Schwartz A; Uriel N
Circulation; 2020 May; 141(20):1648-1655. PubMed ID: 32200663
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2: characteristics and current advances in research.
Yang Y; Xiao Z; Ye K; He X; Sun B; Qin Z; Yu J; Yao J; Wu Q; Bao Z; Zhao W
Virol J; 2020 Jul; 17(1):117. PubMed ID: 32727485
[TBL] [Abstract][Full Text] [Related]
27. Let's talk about sex in the context of COVID-19.
Gargaglioni LH; Marques DA
J Appl Physiol (1985); 2020 Jun; 128(6):1533-1538. PubMed ID: 32437244
[TBL] [Abstract][Full Text] [Related]
28. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
Tseng YH; Yang RC; Lu TS
Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
[TBL] [Abstract][Full Text] [Related]
29. Sex-derived attributes contributing to SARS-CoV-2 mortality.
Chanana N; Palmo T; Sharma K; Kumar R; Graham BB; Pasha Q
Am J Physiol Endocrinol Metab; 2020 Sep; 319(3):E562-E567. PubMed ID: 32726128
[TBL] [Abstract][Full Text] [Related]
30. [Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].
Kreutz R; Abd El-Hady Algharably E; Ganten D; Messerli F
Dtsch Med Wochenschr; 2020 May; 145(10):682-686. PubMed ID: 32323279
[TBL] [Abstract][Full Text] [Related]
31. Exercise as medicine for COVID-19: An ACE in the hole?
Heffernan KS; Jae SY
Med Hypotheses; 2020 Sep; 142():109835. PubMed ID: 32428811
[No Abstract] [Full Text] [Related]
32. JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
Seif F; Aazami H; Khoshmirsafa M; Kamali M; Mohsenzadegan M; Pornour M; Mansouri D
Int Arch Allergy Immunol; 2020; 181(6):467-475. PubMed ID: 32392562
[TBL] [Abstract][Full Text] [Related]
33. Why are women better protected from COVID-19: Clues for men? Sex and COVID-19.
Elgendy IY; Pepine CJ
Int J Cardiol; 2020 Sep; 315():105-106. PubMed ID: 32418736
[No Abstract] [Full Text] [Related]
34. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).
Montopoli M; Zumerle S; Vettor R; Rugge M; Zorzi M; Catapano CV; Carbone GM; Cavalli A; Pagano F; Ragazzi E; Prayer-Galetti T; Alimonti A
Ann Oncol; 2020 Aug; 31(8):1040-1045. PubMed ID: 32387456
[TBL] [Abstract][Full Text] [Related]
35. Rationale for targeting complement in COVID-19.
Polycarpou A; Howard M; Farrar CA; Greenlaw R; Fanelli G; Wallis R; Klavinskis LS; Sacks S
EMBO Mol Med; 2020 Aug; 12(8):e12642. PubMed ID: 32559343
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 and the cardiovascular system.
Hafiane A
Clin Chim Acta; 2020 Nov; 510():311-316. PubMed ID: 32681935
[TBL] [Abstract][Full Text] [Related]
37. The Cross-Talk between Age, Hypertension and Inflammation in COVID-19 Patients: Therapeutic Targets.
Casucci G; Acanfora D; Incalzi RA
Drugs Aging; 2020 Nov; 37(11):779-785. PubMed ID: 33084001
[TBL] [Abstract][Full Text] [Related]
38. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
Verdecchia P; Cavallini C; Spanevello A; Angeli F
Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
[TBL] [Abstract][Full Text] [Related]
39. COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?
Patel AB; Verma A
JAMA; 2020 May; 323(18):1769-1770. PubMed ID: 32208485
[No Abstract] [Full Text] [Related]
40. Drugs and the renin-angiotensin system in covid-19.
Aronson JK; Ferner RE
BMJ; 2020 Apr; 369():m1313. PubMed ID: 32241880
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
